Medication info

Lercardip Tablets (Lercanidipine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Lercanidipine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Hybeast Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 200502175 · Notified 2005.06.29

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of mild to moderate essential hypertension
Who takes it
Adults
Adult dose
○ Adults Administer 5 ~ 10 mg of lercanidipine hydrochloride orally once daily, at least 15 minutes before a meal. The dose may be increased to 20 mg depending on the patient's symptoms. Adjust the dose gradually, as it takes 2 weeks for the maximum blood pressure-lowering effect to become evident. For patients whose blood pressure is not controlled with this medicine, combination therapy with a beta-blocker (e.g., atenolol), diuretic (e.g., hydrochlorothiazide), or ACE inhibitor (e.g., captopril, enalapril) may be used. The dose-response curve is steep and reaches a plateau at doses of 20 ~ 30 mg; doses above this range do not further increase efficacy and may instead increase adverse reactions. ○ Elderly patients: Pharmacokinetic data and clinical experience indicate that no adjustment of the daily dose is required; however, caution is needed when initiating treatment in elderly patients. ○ Patients with hepatic or renal impairment: Particular caution is required during initiation in patients with mild to moderate hepatic or renal impairment. Although the usual dosage regimen can be used in these patients, caution is required when increasing the dose to 20 mg daily. In patients with hepatic impairment, the blood pressure-lowering effect may be increased, and dose adjustment should be considered. Do not administer this medicine to patients with severe hepatic or renal impairment.

Ingredients

Manufacturer
Hybeast Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of mild to moderate essential hypertension

  • Essential hypertension
View approved original text

This medication is used to treat mild to moderate essential hypertension.

How to take

Adult dose

○ Adults Administer 5 ~ 10 mg of lercanidipine hydrochloride orally once daily, at least 15 minutes before a meal. The dose may be increased to 20 mg depending on the patient's symptoms. Adjust the dose gradually, as it takes 2 weeks for the maximum blood pressure-lowering effect to become evident. For patients whose blood pressure is not controlled with this medicine, combination therapy with a beta-blocker (e.g., atenolol), diuretic (e.g., hydrochlorothiazide), or ACE inhibitor (e.g., captopril, enalapril) may be used. The dose-response curve is steep and reaches a plateau at doses of 20 ~ 30 mg; doses above this range do not further increase efficacy and may instead increase adverse reactions. ○ Elderly patients: Pharmacokinetic data and clinical experience indicate that no adjustment of the daily dose is required; however, caution is needed when initiating treatment in elderly patients. ○ Patients with hepatic or renal impairment: Particular caution is required during initiation in patients with mild to moderate hepatic or renal impairment. Although the usual dosage regimen can be used in these patients, caution is required when increasing the dose to 20 mg daily. In patients with hepatic impairment, the blood pressure-lowering effect may be increased, and dose adjustment should be considered. Do not administer this medicine to patients with severe hepatic or renal impairment.

Precautions

This medication should not be administered to certain patients. For example, it is not for those who are allergic to this drug or similar medications, pregnant or breastfeeding women, patients with certain heart-related diseases, severely impaired kidney or liver function, and children and adolescents under 18 years of age. Additionally, patients with arrhythmia, mild to moderate kidney or liver dysfunction, a history of angina, those who consume alcohol frequently, and the elderly should use this medication with caution. While taking this medication, side effects such as facial flushing, peripheral edema, rapid heartbeat, dizziness, headache, indigestion, etc., may occur. Liver function anomalies or skin rashes and muscle pain may also occur rarely, so any abnormal symptoms should prompt a consultation with a physician. If the medication is abruptly discontinued, symptoms may worsen, so the dosage should be gradually reduced. Care should be taken while driving or operating machinery due to potential dizziness or drowsiness. This medication is metabolized in the liver, so drug interactions may occur when taken with certain medications. In particular, caution should be exercised when taking it with certain antifungals, antibiotics, anticonvulsants, immunosuppressants, grapefruit juice, etc., as the effectiveness of this medication may change. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication, and it should not be used in children or adolescents. Special attention is required for the elderly, but generally, dose adjustment is not necessary. In case of overdose, severe hypotension or heart problems may occur, so if an overdose is suspected, immediate medical attention is needed, and this medication may not be removed by dialysis. Finally, this medication should be stored out of the reach of children, and transferring the medication to another container should be avoided.

Side effects

flushing, peripheral edema, palpitations, tachycardia, hypotension, chest pain, angina, headache, dizziness, weakness, fatigue, drowsiness, neurasthenia, dyspepsia, nausea, vomiting, abdominal pain, diarrhea, increase in serum hepatic aminotransferase levels, polyuria, urinary frequency, gingival hyperplasia, rash, myalgia, tremors, insomnia, dry mouth, hand tingling, cough, abdominal bloating, erectile dysfunction, arrhythmia, cold sweat, skin tingling, premature contractions, rigidity of the tongue, increased ventricular premature beats, shortness of breath, gastrointestinal disorders

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to avoid exposure to air and moisture. It is also advisable to store it at normal room temperature, away from excessively hot or cold places.

Appearance and packaging

Appearance

Yellow round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.